TNGX
TNGX
NASDAQ · Biotechnology

Tango Therapeutics Inc

$19.48
+0.52 (+2.74%)
As of Mar 24, 10:02 PM ET ·
Analyst Consensus
Strong Buy
17
Analysts
High
Coverage
Buy 15 88%
Hold 2 12%
Sell 0 0%
Price Target
Analyst Price Target +45.0% upside
Low Target $22.54
Average Target $28.24
High Target $42.65
Current Price $19.48
Current
$19.48
Target
$28.24
$22.54 $28.24 avg $42.65
Scenario Analysis
Bear Case
$22.54
15.7%
Low target
Base Case
$28.24
+45.0%
Avg target
Bull Case
$42.65
+118.9%
High target
Risk/Reward
7.6x
Highly favorable
Price in Context
52-Week High
$13.48
44.5% from high
52-Week Low
$1.03
+1,791.3% from low
Target vs 52W High
$28.24
+109.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +24.3%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -3.7%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -27.6%